Linked Data API

Show Search Form

Search Results

1260539
registered interest false more like this
date less than 2020-12-11more like thismore than 2020-12-11
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Medical Treatments: Coronavirus more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the (a) economic and (b) societal effects of medical treatments are taken into account when assessing medicines, in the context of the approval and procurement of covid-19 vaccine candidates. more like this
tabling member constituency Ashfield more like this
tabling member printed
Lee Anderson more like this
uin 128731 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-04-13more like thismore than 2021-04-13
answer text <p>The Government has accepted the recommendations from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to authorise three COVID-19 vaccines for use - Pfizer/BioNTech, Oxford/AstraZeneca and Moderna. While this approval is not specifically on the basis of economic and societal benefits, it is on the grounds of patient safety. No vaccine would be deployed in the United Kingdom unless the expected standards of safety, quality and efficacy are met.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-04-13T15:27:35.617Zmore like thismore than 2021-04-13T15:27:35.617Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4743
label Biography information for Lee Anderson more like this